Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Chemotherapy Concurrent With Postoperative Radiotherapy Epidermoid Carcinoma of the Head and Neck at High Risk of Recurrence - Study of Feasibility

NCT00006051 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00006051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Chemotherapy Concurrent With Postoperative Radiotherapy Epidermoid Carcinoma of the Head and Neck at High Risk of Recurrence - Study of Feasibility
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
February 28, 1999
Completion date
September 30, 2005
Enrollment
Not reported
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer